Home » ‘Arrogance kills’: Novo chief injects risk-taking into Ozempic maker

‘Arrogance kills’: Novo chief injects risk-taking into Ozempic maker

‘Arrogance kills’: Novo chief injects risk-taking into Ozempic maker

This post was originally published on this site.

Mike Doustdar says he is open to ‘large’ deals and group will suffer ‘failures’ as it tries to cut reliance on weight-loss drugs